Cart 2

Brentuximab vedotin (Synonyms: BRENTUXIMAB [VANDF])

Cat.#: 176856

Size:

Special Price 301.5 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Brentuximab vedotin (Synonyms: BRENTUXIMAB [VANDF])
  • Documents
  • Description
    Anti-TNFRSF8 / CD30 Antibody (Brentuximab vedotin)
  • Tested applications
    ELISA
  • Species reactivity
    Human TNFRSF8 / CD30
  • Alternative names
    BRENTUXIMAB [VANDF] antibody
  • Isotype
    IgG1
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SDS-PAGE

    SDS-PAGE

    Anti-TNFRSF8 / CD30 Antibody (brentuximab vedotin) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-TNFRSF8 / CD30 Antibody (brentuximab vedotin) is 98.99%, determined by SEC-HPLC.

    HIC

    HIC

    MMAE is conjugated by sulfhydryl coupling,the DAR value of Anti-TNFRSF8 / CD30 Antibody (brentuximab vedotin) antibody is 4.0.

    Bioactivity: ELISA

    Bioactivity: ELISA

    Immobilized human CD30 His at 2 ug/mL can bind Anti-TNFRSF8 / CD30 Antibody (brentuximab vedotin), EC50 is 0.006007 ug/mL.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"